metyrapone has been researched along with Bonnevie-Ullrich Syndrome in 7 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Bonnevie-Ullrich Syndrome: This syndrome that was originally observed by Ullrich, and designated as identical to TURNER SYNDROME, related the webbing of the neck, loose skin and other anomalies of the syndrome to accumulation of fluid in the embryo starting at the head and dispersing to the extremities (as observed by Bonnevie in mice). Commonly observed at birth in Turner Syndrome and NOONAN SYNDROME; EDEMA of the extremities usually recedes by one year and is an early sign of Turner syndrome, especially in female neonates.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The parameters investigated were plasma GH and cortisol responses to hypoglycemia, plasma cortisol circadian rhythm and suppressibility by dexamethasone, and response of urinary Porter-Silber chromogens to metyrapone." | 3.68 | Growth hormone and ACTH secretory dynamics in Turner's syndrome. ( Catania, A; D'Alberton, A; Motta, T; Reschini, E, 1990) |
| "A case of Turner's syndrome with short stature and 45, XO/46, XXr mosaicism in chromosome study was presented." | 1.25 | A case report of Turner's syndrome with ring X chromosome. ( Fujii, S; Fujita, H; Morii, H; Otsuka, Y; Tanaka, K; Wada, M, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MESTMAN, JH | 1 |
| NELSON, DH | 1 |
| Tanaka, K | 1 |
| Otsuka, Y | 1 |
| Fujii, S | 1 |
| Morii, H | 1 |
| Wada, M | 1 |
| Fujita, H | 1 |
| Reschini, E | 1 |
| D'Alberton, A | 1 |
| Catania, A | 1 |
| Motta, T | 1 |
| Igarashi, Y | 1 |
| Hanada, S | 1 |
| Nishida, S | 1 |
| Nakajima, T | 1 |
| Sabeh, G | 1 |
| Alley, RA | 1 |
| Narduzzi, JV | 1 |
| Weir, TF | 1 |
| McGowen, CH | 1 |
| Robbins, TJ | 1 |
| Danowski, TS | 1 |
7 other studies available for metyrapone and Bonnevie-Ullrich Syndrome
| Article | Year |
|---|---|
INHIBITION BY ESTROGEN ADMINISTRATION OF ADRENAL-PITUITARY RESPONSE TO METHOPYRAPONE.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Diabetes Mellitus; Estrogens; Hypothyroidism; Ketones; | 1963 |
A case report of Turner's syndrome with ring X chromosome.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Arginine; Cells, Cultured; Chromosome | 1975 |
Growth hormone and ACTH secretory dynamics in Turner's syndrome.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Child; Circadian Rhythm; | 1990 |
[Studies on the pituitary ACTH secretory capacity in children using 11-beta-hydroxylase inhibitor (Metopirone). 2. Diagnostic value in pituitary dwarfism in children].
Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Child; Child, Preschool; Dwarfism; | 1966 |
Studies on hypothalamo-pituitary-adrenocortical function of patients with the syndrome of gonadal dysgenesis.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Dexa | 1971 |
[Pituitary function test using synthetic lysine-8-vasopressin--comparison with metopirone test and insulin stress test].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anorexia Nervosa; Craniopharyngioma; Cushing S | 1971 |
Hyperresponsiveness to metyrapone.
Topics: Adrenal Cortex Hormones; Anorexia Nervosa; Diabetes Mellitus; Growth; Growth Disorders; Humans; Hypo | 1967 |